Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04637321 · ClinicalTrials.gov registry record
The Incidence and Risk Factors for Clostridioides Difficle Infection in Solid Organ Transplant Recipients
A clinical trial, sponsored by Methodist Health System.
- Completed
- Registry status
- 585
- Enrollment target
NCT04637321 is a clinical trial that has completed, run by Methodist Health System. The registered enrollment target is 585 participants.
The verdict
NCT04637321 has completed, sponsored by Methodist Health System.
- COMPLETED
- Registry status
- 585 participants
- Enrollment target
Study Summary
2.1. Study Objectives * Primary Objective(s) * Identify the incidence and risk of CDI within one year after kidney, liver, and/or pancreas transplant * Secondary Objective(s) * Identify the risk factors for recurrent CDI post-transplant in patients who were diagnosed with a CDI within one year prior to Solid Organ Transplant * Evaluate the impact of CDI on graft survival following Solid Organ Transplant
Interventions
- PROCEDURE Solid organ transplant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 585 participants |
| Start Date | 2019-11-04 |
| Est. Completion | 2020-08-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04637321
The ClinicalTrials.gov registry entry for NCT04637321 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 585 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Methodist Health System, which has 125 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Solid organ transplant is the first listed.
NCT04637321 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04637321 about?
NCT04637321 is a clinical study titled "The Incidence and Risk Factors for Clostridioides Difficle Infection in Solid Organ Transplant Recipients". 2.1. Study Objectives * Primary Objective(s) * Identify the incidence and risk of CDI within one year after kidney, liver, and/or pancreas transplant * Secondary Objective(s) * Identify the risk factors for recurrent CDI post-transplant in patients who were diagnosed with a CDI within one year prio...
What is the current status of trial NCT04637321?
This trial is currently completed. The enrollment target is 585 participants. The study started on 2019-11-04. Estimated completion is 2020-08-07.
What interventions are being tested in trial NCT04637321?
The interventions under investigation include: Solid organ transplant (PROCEDURE).
Who is sponsoring clinical trial NCT04637321?
This trial is sponsored by Methodist Health System, which has 125 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.